ERIN AFABLE: Open Payments
NPI 1114677697 · MIDDLEBURG HEIGHTS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 20 payments from 9 companies in 2025. Trend: 2023 $542 · 2024 $358 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| Genentech USA, Inc. | 3 | $76 |
| CSL Behring | 2 | $69 |
| Novartis Pharmaceuticals Corporation | 1 | $53 |
| Galderma Laboratories, L.P. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Verona Pharma, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: Xolair, FASENRA, Rhapsido, NUCALA, Andembry, TRELEGY ELLIPTA, Haegarda, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
